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Initial development of a cytotoxic amino-seco-

Introduction
Duocarmycin SA 1 (Scheme 1) is a natural product of the cyclopropapyrroloindole (CPI) class with exquisitely potent cytotoxicity, having IC 50 = 10 pM in L1210 cells. 1 It acts by binding in the minor groove of DNA, with consequent alkylation by the strained spirocyclopropane ring. In the structure of the related natural product CPI 2 (CC1065), the side-chain, which binds non-covalently in the minor groove of DNA prior to covalent reaction, is extended to interact over a longer section of the groove. This also provides high cytotoxic potency for this compound (IC 50 = 24 pM in L1210 cells). 2 The semisynthetic experimental drug adozelesin 3 carries the same CPI war-head as does 2 but the side-chain is simplified; the binding of this molecule into the minor groove as a -stacked dimer has been studied in depth. 3 The non-covalently-binding units can also be displayed on each side of the CPI, as in yatakemycin 4, 4, 5 increasing potency yet further (IC 50 = 5 pM in L1210 cells). However, this extreme cytotoxicity is not selective for tumour cells; compounds such as 2 also cause a delayed lethality in mice and rabbits. 6, 7 This lack of selectivity has led to research on the development of prodrugs designed to release the potent cytotoxins selectively in tumour tissue. Many of these prodrugs release the cyclopropabenzaindole (CBI) alkylating warhead, rather than CPI; these alkylating units have similar potency but improved stability and synthetic accessibility. 8, 9 Tietze has disclosed a prodrug 5, in which the exocyclic OH of the seco compound is masked as a -D-galactoside. 10, 11 This prodrug is essentially non-toxic until the -D-galactoside is cleaved by a -D-galactosidase in the context of ADEPT; Winstein cyclisation then gives the active CBI. The exocyclic oxygen is masked as a cyclic hydroxamate ester in 6; bioreductive cleavage of the N-O bond exposes the phenol, triggering the required Winstein cyclisation. 12 Bioreduction of the nitro group to amino in hypoxic tumour cells is also required for activation of the nitro-prodrug 7. 13 The amine then promotes Winstein cyclisation, with a sulfonate as the leaving group; 7 shows ~1000-fold selectivity for killing hypoxic HT29 human colon cancer cells vs. oxic HT29 cells in vitro. Oxidative activation is required for seco-CPI prodrugs such as 8, developed by the Bradford group. 14 Metabolic oxidation, by CYP1A1 or CYP2W1 (over-expressed in some tumours) gives 9, from which Winstein cyclisation leads to the active cytotoxin 10 (Scheme 1).
Many of these prodrugs are activated by reduction or oxidation, with only 5 requiring enzyme-catalysed hydrolysis. As part of our studies towards prodrugs where seco-CBIs are released by tumour-specific peptidases, we sought an appropriate seco-CBI carrying an amine at the 5-position for linkage to the peptide through an amide bond. Figure 1 shows our general design of target 5-amino-secoCBIs for later linkage to masking peptides. 5-Hydroxy-seco-CBIs would be inappropriate, as the link to the peptides would have to be aryl esters, which may be chemically labile in biofluids. Figure 1 shows the general design of the target 5-amino-secoCBIs as structure 11. In this structure, X represents a suitable leaving group (tuned to provide a balance of reactivity and stability), R represents a suitable acid-labile protecting group (or H), R' represents substitution on the indole side-chain. This substitution may be the OH or OMe groups found in natural CPIs (contributing to non-covalent binding in the minor groove), additional indole or benzofuran units (also contributing to binding) or water-solubilising entities. Structure 12 is the specific target for the present work. Here, the leaving group X is simply a chloride (as in many seco-CPIs and seco-CBIs) and the side-chain extension is the water-solubilising dimethylaminoethoxy group used by Tietze et al. 10 in their galactosidase-activated prodrug 5.
Results & discussion
Design of a protected seco-CBI
Chemical synthesis
The key step in assembling the target seco-CBI-warhead 12 is cyclisation of a suitable 1,2,4-trisubstituted naphthalene. Two cyclisations were investigated: intramolecular 5-exo reaction of a chiral 1-metallo-2-oxiranylmethylaminonaphthalene (to give enantiopure material) and radical 5-exo cyclisation of a 1-iodo-2-allylaminonaphthalene (giving a racemate).
Both routes required an orthogonally protected 1-iodonaphthalene-2,4-diamine. Scheme 2 shows the routes investigated thereto. Firstly, attempted nitration of 4-aminonaphthalen-1-ol 13 towards 4-amino-2-nitronaphthalen-1-ol failed, giving only naphtho-1,4-quinone 14 by oxidation. Martius Yellow 15 is a convenient starting material, with the correct pattern of functionalities on the naphthalene ring, although the nitro groups need to be discriminated. Selective reduction of the 4-nitro group with tin(II) Scheme 1. Structures of CPI extreme cytotoxins duocarmycin SA 1, CC1065 2, adozelesin 3 and yatakemycin 4 and of seco-CBI prodrugs 5-7; also metabolic oxidation of seco-CPI prodrug 8 by CYP1A1 and CYP2W1, leading to insertion of the phenol in 9 and Winstein cyclisation to the active CPI cytotoxin 10. chloride, in a modification of the literature method, 15 afforded 16. Attempted protection of the aniline under basic conditions gave only the carbonate 17, arising from reaction at the more nucleophilic phenoxide anion. Under neutral conditions, the amine of 16 is more nucleophilic towards Boc 2 O, giving 18 in excellent yield. The phenol was readily triflated but the attempted replacement of OTf in 19 with iodine to give 20 failed; this had previously been successful in the conversion of 23 to 24. 16 An attempt to remove the triflyloxy group reductively (aiming for N-Boc 3-nitronaphthalene-1-amine) served only to cleave the OS bond to regenerate 18. With that avenue closed, attempts were made to reduce the nitro group of 18 to the corresponding amine, before orthogonal protection and introduction of iodine. Hydrogenolysis proceeded well in the presence of Pd but all attempts to isolate the very electron-rich naphthalene product failed, giving the NBoc naphthoquinoneimine 21. Reduction, followed by trifluoroacetylation, gave orthogonally protected 22 in moderate yield but no routes could be found to elaborate this towards 29.
An alternative route was investigated, in which discrimination between the nitrogens was achieved by selective protection of the diamine 25. As reported previously, 16 the phenolic OH of 15 was triflated to give 23 and S N Ar reaction with iodide ion furnished 24. From here, reduction of the nitro groups also caused loss of the iodine, affording naphthalene-1,3-diamine 25. This electronrich naphthalene is unstable to autoxidation, so it was protected as the diBoc derivative 26. The iodine was restored electrophilically with electrophilic iodine generated from N-iodosuccinimide and toluenesulfonic acid, affording 27. However, all attempts to remove one Boc group selectively from 27 failed, with many acidic conditions also causing loss of the iodine, through a Wheland intermediate which was observed by NMR. 16 Changing the point at which selectivity is achieved to the protection step, rather than deprotection, treatment of 25 with trifluoroacetic an- hydride under very mild conditions led to reaction at the lesssterically-encumbered 3-NH 2 ; subsequent protection of the 1-NH 2 with Boc led to the orthogonally protected diamine 28 in modest yield. As for 26→27, 28 was iodinated electrophilically to provide the key intermediate 29.
Scheme 3 shows the preparation of the non-covalently binding and water-solubilising indole side-chain. The carboxylic acid of 30 was protected as the ethyl ester 31 before the corresponding phenoxide was alkylated with N-(2-chloroethyl)dimethylamine to afford 32. Hydrolysis of the ester with caesium carbonate in aqueous methanol gave the required carboxylic acid 33.
With these building blocks in hand, methods were investigated to build the target seco-CBIs. Initial attempts sought to exploit the ring-closure developed by Tietze et al., 17 in which the protected iodo-(oxiranylmethylamino)naphthalene 34 is metallated with a higher-order lithium cuprate (replacing the iodine); attack of the aryl-copper on the oxirane then proceeds with chelation-controllled regioselectivity and stereoselectivity to form 35 (Scheme 4). The 4-nitrobenzenesulfonate (nosylate) ester 37 of R-glycidol 36 was formed in the usual way; this leaving group was selected as this and similar oxiranylmethyl nosylates react with nucleophiles strictly in an S N 2 manner, 17 retaining the configuration at the oxirane. The F 3 CCON-H is the more acidic in 29 and selective alkylation of the corresponding anion with 37 afforded 38 in good yield. Interestingly, 38 was formed as a mixture of chromatographically separable diastereomeric atropisomers 38A and 38B. The bulky iodine twists the N-oxiranylmethyltrifluoroacetamide out of the plane of the naphthalene by rotation about the naphthalene-N bond, generating a chiral centre. Interconversion of the atropisomers by rotation about this C-N bond is so severely impeded that it does not occur at ambient temperature. Owing to the presence of the conventional R-chiral centre in the oxirane, the atropisomers are diastereomeric.
1 H, 13 C and 19 F NMR analysis of atropisomer 38A also showed a 3:2 mixture of rotamers; this probably reflects restricted rotation of the tertiary amide carbonyl-N bond in the trifluoroacetamide. No similar rotamers were evident in the corresponding spectra of 38B, suggesting that one rotamer about the amide bond predominates greatly in this diastereoisomer. Figure 2 shows the proposed structures of these atropisomers, using structures minimised in Sybyl and rendered with Accelrys DS.
Unfortunately, the metalation / cyclisation reaction developed by Tietze et al. 17 failed to form 39 from a mixture of diastereoisomers of 38 The only isolable product (in high yield) was 40, derived from loss of the F 3 CCO protection (Scheme 4). We speculate that the failure to cyclise was due to the presence of the BocN-H, which may have quenched the cuprate before it could engage in metallation. Nucleophilic -CN may then have cleaved the trifluoroacetamide. The NMR spectra of 40 showed the presence of the diastereomeric atropisomers, which were not separable in this case. Furuyama et al. reported that 4-iodophenol (carrying an acidic proton) is readily metallated with Bu t 4 ZnLi 2 and the arylzinc reacts with allyl bromide to give exclusively 4-allylphenol. 18 This process also failed to cyclise 38 to 40, giving only unreacted 38. The door was closed on this potential route to homochiral CBIs carrying NHBoc.
Therefore, a route was developed in which cyclisation of an achiral starting material would give a seco-CBI in racemic form. Boger and McKie carried out a 5-exo radical cyclisation of 2-(Nallyl-BocN)-4-benzyloxy-1-iodonaphthalene with TEMPO and Bu 3 SnH to afford racemic 5-BnO-3-Boc-1-(2,2,6,6-tetramethylpiperidin-1-yloxy)methyl)-2,3-dihydrobenzo[e]indol-5-yl)carbamate. 19 Similar cyclisations have been disclosed by Stevenson et al. 13 Alkylation of 29 with allyl bromide in the presence of excess K 2 CO 3 (Scheme 4) introduced two allyl groups (forming 41) but selectivity for the more acidic N-H was achieved using one equivalent of KOBu t to form the monoanion, leading to 42. As for 38, 42 formed two separable but non-interconvertible conformers, in a 4:1 ratio. Clearly, one of the centres of atropisomerism is the naphthalene-N(allyl)COCF 3 bond which is restricted by the adjacent iodine but one may only speculate that the other source of atropisomerism may be the naphthalene-NHBoc bond, the rotation of which might be impeded by the peri 5-H. Cyclisation of the atropisomeric mixture to 43 was achieved in 60% yield using TEMPO and Bu 3 SnH in boiling benzene. Tricycle 43 contains the three groups protected with completely mutually orthogonal masking groups. Selective basic hydrolysis of the trifluoroacetyl protection revealed the secondary amine in 44, to which the 5-(2-dimethylaminoethoxy)indole-2-carbonyl side-chain was affixed in a carbodiimide coupling, affording 45. The O-(2,2,6,6-tetramethylpiperidin-1-yl) protection was removed reductively, after much optimisation. Reaction of 45 with zinc powder in THF / AcOH / H 2 O (1 : 3 : 1) gave a mixture of 46-49, in which the NBoc had been removed in 46 and 48 and the exposed alcohol had been esterified in 48 and 49. Zinc acetate is a known Lewis acid catalyst for acetylation of primary alcohols. 20 The amine 48 was reprotected to give 49. Reduction of 45 under less acidic conditions (THF / AcOH / H 2 O (3 : 1 : 1)) allowed uneventful cleavage of the N-O bond to provide 47 in good yield. It only remained for the OH to be converted into the chloride and for the N-Boc to be removed. Reaction of 47 with mesyl chloride in DMF in the presence of Et 3 N aimed to form the mesylate, which would be displaced by chloride ion from added excess LiCl. These conditions introduced the required chlorine but reaction of the MsCl with solvent DMF generated a Vilsmeier reagent, which cleaved the N-Boc and formed the dimethylformamidine in 50. Use of stoichiometric MsCl in pyridine obviated this side-reaction to generate the required protected seco-CBI 51. Finally the Boc protection was acidolysed to form 52 as the stable dihydrochloride, with the cation being unable to trigger Winstein cyclisation.
Biochemical and cell-biological evaluation
The CBIs act by binding and alkylating in the minor groove of DNA. When they do so, they cause an increase in the temperature at which the strands of double-stranded DNA separate, the socalled melting temperature (T m ). Indeed, the CPI CC-1065 2 causes an increase in T m of up to 31 deg. C.
2 Thus, to confirm that the seco-CBI 52 did form a DNA-reactive entity (presumably the CBI 53 formed by Winstein cyclisation (Scheme 5)) in aqueous buffer at pH 7.0 and that the expected 53 did bind and react with double-stranded DNA, a DNA-melting study was carried out. Firstly, to ensure that the putative electrophile 53 was fully formed in the buffer, the dihydrochloride salt of 52 was incubated with double-stranded calf-thymus DNA in phosphate buffer at pH 7.0 for 1 h and for 24 h and the increase in melting temperature (T m ) was determined for both incubations. The identical values demonstrated that the naphthylamine was present as the free base at pH 7.0 and that formation of an electrophilic product (putatively 53) was complete within 1 h. Thus the full DNAmelting study was conducted with an incubation time of 1 h (Figure 3) . Panel A shows the primary changes in UV absorption at 256 nm with temperature, using nine different molar ratios of 52/53 to DNA (calculated per base-pair), whereas panel B shows the first derivative of these primary curves, allowing the T m to be determined as the temperature at the apex of the derivative curve. In panel C, T m is plotted against the molar ratio of 52/53 per DNA base-pair. The data confirm that generation of the electrophile (putatively 53) takes place rapidly at pH 7.0 and that it does bind to and alkylate double-stranded DNA, giving a maximum T m of 13 deg. C. This maximum is achieved with ca. 0.2 drug molecules per base-pair. Of course, 52 and 53 are racemates. It is known that only one enantiomer of CBIs binds strongly to DNA, the other having a shape which does not match the curve of the minor groove. Indeed, (-)-duocarmycin SA 1 alkylates DNA at least ten-times more efficiently than does its (+)-enantiomer. 21 Thus it may be argued that the appropriate ratio to consider is the ca. 0.1 ratio of the correct enantiomer per base-pair.
The cytotoxicity of 52 (presumably forming 53) towards LNCaP human prostate carcinoma cells was measured using the MTS assay. This cell line produces Prostate-Specific Antigen (PSA) and its proliferation is sensitive to androgens. 22 An IC 50 of 18 ± 3 nM was observed for the antiproliferative effect on these cells. To demonstrate that masking the naphthylamine with a carbonyl (in the Boc-protected precursor 51) does diminish the cytotoxic potency, a similar assay was conducted for 51. This compound indeed proved to be markedly less active, with IC 50 = 218 ± 47 nM. In each case, only one of the enantiomers is likely to be potent.
Conclusions
In this paper, the challenge of assembling a seco-CBI carrying a protected amine at the 5-position has been overcome. The key steps were preparation of the orthogonally protected 1-iodonaphthalene-2,4-diamine 29, allowing selective allylation at the 2-trifluoroacetamido group, and radical 5-exo ring-closure of the N-allyl compound 42 to the seco-CBI core in 43. This cyclisation uses an achiral educt and achiral reagents, leading to racemic 43. The biological activities of CBIs (binding in the minor groove of double-stranded DNA, cytotoxicity) reside in one enantiomer only; the development of a stereoselective radical ring-closure will be the subject of a later publication. This route has the benefit that 43 contains three functionalities with completely orthogonal protection; the OH is protected by the O-tetramethylpiperidine (removable by reduction), the secondary amine site for introduction of the non-covalently bonding side-chain is protected as the base-labile trifluoroacetamide and the primary aniline (later to trigger Winstein cyclisation) is masked by the acid-labile Boc group. These benefits were exploited by firstly exposing the pyrrolidine nitrogen and attaching the indole side-chain in 45. The OH was revealed and converted into the required leaving group in 51. The target amino-seco-CBI 52 was generated by simple rapid acidolysis of the Boc protection. The mutual orthogonality of the protection in 43 means that this intermediate is potentially highly versatile, with opportunities to modify the order in which the subsequent steps are carried out, leading to access to diverse amino-seco-CBIs and to the potential for attaching the deactivating prodrug linker to the 5-NH 2 prior to "arming" the seco-CBI warhead by installing the leaving group.
Confirmation that the amino-seco-CBI system is a useful warhead for release / delivery by peptide prodrugs was provided by allowing 52 to undergo Winstein cyclisation in aqueous buffer at pH 7.0 to provide the CBI 53. This was demonstrated to be complete in < 1 h by the equivalence of DNA-binding at 1 h and 24 h time-points. DNA-melting studies showed the generated 53 to bind to and react with double-stranded DNA in the stoichiometry of 0.2 molecules per base-pair (0.1 molecules if only the active enantiomer is considered). The delivered CBI is also a highly potent cytotoxin towards LNCaP human tumour cells, with IC 50 in the nanomolar range. Further studies optimising the potency of this warhead towards the picomolar range of 1-4 by modifying the non-covalently-binding side-chain will be published later.
Thus we have identified 43 as an important core intermediate for development of potential warheads of extreme potency for selective delivery through peptide prodrug systems.
Experimental section
General
H and
13 C NMR spectra were recorded at 400.04 or 500.13 MHz for 1 H NMR and 100.59 or 125.76 MHz for 13 C NMR using CDCl 3, containing SiMe 4 , unless otherwise noted. 13 C NMR spectra were assigned using HSQC and HMBC. MS data were obtained using electrospray ionisation using a microTOF instrument (Bruker Daltonics, Bremen, Germany), calibrated using sodium formate. Mps were obtained using a hot-stage microscope (Reichert-Jung). Experiments were conducted at ambient temperature, unless otherwise noted. Solutions in organic solvents were dried with , 8-H or 7-H), 7.51 (1 H, s, 4-H), 7.69 (2 H, m, 6,9-H 2 ) ; 13 Water (1.0 mL), Zn dust (934 mg, 14.4 mmol) and AcOH (1.0 mL) were added sequentially to 45 (123 mg, 0.18 mmol) in THF (3.0 mL). The mixture was heated at 70C in a sealed pressure tube for 16 h. The cooled mixture was filtered (Celite ® ) and the solvents were evaporated. Sat aq. NaHCO 3 was added and the suspension was extracted (EtOAc). The extract was washed (water, brine 
DNA-melting studies
The buffer was prepared by dissolving NaH 2 PO 4 (1.17 g, 9.75 mM), ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate (372 mg, 1.0 mM) and NaCl (438 mg, 7.5 mM) in 18.2 M MilliQ water (800 mL). The pH was adjusted to pH 7.0 using aq. NaOH (0.1 M) or aq. HCl (0.1 M) as required and Milli-Q water was added to 1.00 L. The calf thymus DNA stock solution was prepared by dissolving DNA in 9.75 mM phosphate buffer to a concentration of 1.0 mg mL -1 . The stock was diluted with buffer until an absorbance of 0.6 at 256 nm was obtained. This gave a concentration of ca. 32 g mL -1 , using the BeerLambert Law with  = 6600 M -1 cm -1 . Compound 52 (1.04 mg, 1.94 mol) was dissolved in DMSO (1.00 mL) to make a stock solution. Different volumes of this solution were added to the DNA solution (3.00 mL) in the appropriate quartz cuvettes and the mixtures were incubated at room temperature for 1.0 h to allow alkylation of the DNA. Five parallel cuvettes were prepared: A: blank containing buffer and DMSO (40 L); B,C: controls containing DNA, buffer and DMSO (40 L); D,E: tests containing 52/53, DNA, buffer and DMSO. All cuvettes contained the same total volume of DMSO (40 L). The absorbance at 256 nm was monitored for each sample over the range of 40C → 95C with the temperature rising at a rate of 0.5 deg. C min -1 , using a complete PC-controlled spectrometer system (Perkin Elmer Lambda BioDNA Melt system including PTP-6 temperature-controlled programmer for simultaneous curves, UVTemplab software and in-cuvette temperature sensor). Both direct and first-derivative graphs were plotted and the T m was taken as temperature at the maximum in the first-derivative plot.
Cytotoxicity assays
The human prostate cancer cell line LNCaP (Sigma-Aldrich) was cultured in Dulbecco's Modified Eagle's Medium (DMEM) with high glucose (4.5 g L -1 ), foetal bovine serum (FBS, 20% (v/v)), penicillin (100 U mL -1 ) and streptomycin sulfate (100 μg mL -1 ) at 37C in a humidified atmosphere containing 5% CO 2 (v/v). The MTS assay was conducted as described previously. 23 
